ArticleNeuropsychiatric disease and treatment2017

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.

Jingping Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.